NCT05580315 (DiMe) is a clinical trial in Discoid Meniscus of Knee, sponsored by University of Milano Bicocca.

Who is sponsoring NCT05580315?

NCT05580315 is sponsored by University of Milano Bicocca.

What condition does NCT05580315 study?

NCT05580315 studies Discoid Meniscus of Knee.

Is NCT05580315 still recruiting?

NCT05580315 is currently recruiting now. Last updated 25 July 2025.

Last reviewed 2025-07-25 · How we verify

NCT05580315: DiMe

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EPOS Discoid Meniscus (DiMe) Project

Recruiting now Last updated 25 July 2025

What this trial tests

trial in Discoid Meniscus of Knee in 500 participants. Currently enrolling.

Timeline

8 September 2022

Primary endpoint
1 September 2042

1 September 2042

Quick facts

Lead sponsor	University of Milano Bicocca
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	500
Start date	8 September 2022
Primary completion	1 September 2042
Estimated completion	1 September 2042
Sites	12 locations across France, Italy, Finland, Belgium, United Kingdom, Switzerland, Portugal

Conditions studied

Discoid Meniscus of Knee — all drugs for Discoid Meniscus of Knee →

Sponsor

University of Milano Bicocca

Who can join

Adults 1 to 18, any sex, with Discoid Meniscus of Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aims of this Discoid Meniscus (DiMe) project are to analyze DM tears characteristics in the pediatric European population to describe current treatment options in symptomatic DM, and to evaluate clinical outcomes. To reach these objectives, a prospective database including symptomatic DM and variables associated with DM characteristics, type of tears, treatment, imaging, and clinical follow-up will be implemented. Data collection platform will provide future studies to understand the best treatment option for skeletally immature patient with symptomatic DM according to their history and lesion characteristics.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Barriers to conducting prospective multicentre studies in paediatric orthopaedics in Europe: Insights from the EPOS Discoid Meniscus (DiMe) project.
Turati M, Crippa M, Nicolaou N, Tassistro E, et al · · 2026 · PMID 41769156 · DOI 10.1177/18632521261424747

Verify or expand the search:

Other University of Milano Bicocca trials

Trials by the same sponsor.

NCT07257705 — Pilot Trial of a Clinical Decision-Support App for Managing Emergencies Among Clinicians in a Rural Ugandan Hospital · NA · completed
NCT07457138 — Lombard Cohort of Brain Health Services · recruiting
NCT07407608 — ABlative Radiotherapy (for) Unfavorable Prostate Tumors 2.0 · recruiting
NCT07479914 — Art of Memory for Cognitive Enhancement in the Monza Brain Health Service · NA · active not recruiting
NCT07424066 — Non-invasive Vibratory Stimulation of the Knee Muscles for the Improvement of the Somatosensory Input and Motor Performa · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05580315 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Milano Bicocca
Last refreshed: 25 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05580315.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing